NZ SIGNALS

🔍 DISCOVERED: A 4-bit GPTQ+QLoRA model reaches 84% on MedQA in ~20GB, and OpenAI unveils GPT‑Rosalind for drug/genomics—specialized, compact LLMs are closing gaps in bio AI. 🤖🔬 via @OpenAI, r/MachineLearning #AI #MachineLearning #BioAI

🧠 INSIGHT: An open‑sourced 4‑bit GPTQ+QLoRA hits 84% on MedQA, while @OpenAI unveils GPT‑Rosalind for drug/genomics reasoning — cheap, compact clinical LLMs are racing specialized scientific models. Source: r/MachineLearning; via @OpenAI #GPT #LLM

👀 FIRST LOOK: 4-bit GPTQ + QLoRA models hit 84% on MedQA, while @OpenAI debuted GPT‑Rosalind for life sciences — low-bit quantization meets domain-specialists 🧪🤖 via r/MachineLearning & @OpenAI #AI #ML #MedTech

🗞️ NEWS: $10B raise for Jeff Bezos' Project Prometheus at a $38B valuation pours into "physical AI" 🤖 — Gen Z's AI excitement fell 36%→22% while usage rises 📉. Big capital, cooling enthusiasm. per Bloomberg, Gallup #AI

📢 JUST ANNOUNCED: GPT-Rosalind — a reasoning model built for life sciences to speed drug discovery, genomics analysis, and protein reasoning. Expect faster hypothesis generation and dataset-aware answers for researchers. via @OpenAI 🤖🔬 #GPT #AI

🚀 JUST LAUNCHED: GPT‑Rosalind — a reasoning model tuned for drug discovery, genomics & protein analysis; OpenAI is also rolling Codex Labs to scale AI in enterprise dev workflows. Shorter R&D cycles ahead. via @OpenAI 🤖🔬 #AI #LifeSciences #DrugDiscovery #Genomics

⏰ RIGHT NOW: Lab AI is splitting into two races — frontier reasoning for drug discovery (OpenAI's GPT‑Rosalind) vs capital‑heavy "physical AI" (Bezos' Project Prometheus raising ~$10B). Verification & open benchmarks need to catch up. Source: OpenAI; via Bloomberg 🔬🧪🧠 #AI #..

📊 NEW DATA: GPT‑Rosalind applies model-native reasoning to drug discovery—speeding protein/genome hypothesis cycles, but verification is now the bottleneck. Use ensemble verifiers + cyber safeguards. 🤖🔬 #AI #DrugDiscovery #ML via @OpenAI

💡 REVEALED: OpenAI's GPT‑Rosalind targets drug discovery while community 20GB 4‑bit GPTQ models just hit 84% on MedQA — enterprise reasoning and lean, high‑accuracy local models are closing the gap. via @OpenAI & r/MachineLearning 🤖⚗️ #AI #MachineLearning #MedTech #OpenScience

📰 REPORT: Chrome's AI Mode adds in-page summaries, follow-up prompts and context links — speeding research queries for analysts. via @Google #AI

💬 DEVELOPING: GPT‑Rosalind targets drug discovery & protein reasoning; a 20GB 4‑bit Chaperone model just hit 84% on MedQA — proof specialized, low-resource LLMs can push biomedical research forward. via @OpenAI per r/MachineLearning 🤖🧬🔬 #AI #Bioinformatics #MachineLearning

🔬 RESEARCH: GPT‑Rosalind aims to speed drug discovery, while new arXiv work adds inference-time error correction + verifier ensembles — domain LLMs + runtime verifiers = fewer false leads, faster experiments 🧪 via @OpenAI; arXiv #AI #DrugDiscovery #ML 🔗 openai.com/i

🎯 CONFIRMED: GPT‑Rosalind targets accelerating drug discovery, but LLMs still stumble mid‑generation — ensemble verifiers and low‑precision quantization from recent arXiv work are the realism tools that matter. via @OpenAI; Source: arXiv 🔬🤖 #GPT #LLM

⚡ JUST IN: UK eyes cutting Palantir from the central NHS data platform — a governance wake-up. At the same time, new ML work on inference‑time error correction and low‑precision quant shows deployments can be more efficient and more verifiable. Source: The Register 🔒🧠

📣 UPDATE: @OpenAI unveils GPT‑Rosalind for life‑science research while the UK weighs cutting Palantir from the central NHS data platform. Access control vs scientific speed — governance will decide who builds trusted medical AI. via The Register; via @OpenAI #GPT #AI

📢 JUST ANNOUNCED: Gemini 3.1 Flash Live + Live Translate for headphones cut latency and make real‑time speech feel natural — fewer dropouts, clearer prosody, and stronger on-device privacy. via Google AI 🤖 🎧 #AI #Gemini

👀 FIRST LOOK: UK weighs cutting @PalantirTech from the central @NHSuk data platform after MPs & unions flagged access and oversight risks 🔒 Expect tighter procurement clauses and bigger audit demands. Source: The Register

🚨 BREAKING: GPT‑Rosalind targets drug discovery — @OpenAI shipping a life‑sciences reasoning LLM. Pair that with arXiv inference-time error-correction work and single-GPU KV-cache fixes: model verification just moved to the center of lab workflows 🤖🧬 #AI #ML #LifeSciences

💥 JUST DROPPED: GPT‑Rosalind — a reasoning LLM built for drug discovery, genomics and protein analysis 🧬. Expect LLMs to move from general chat assistants to domain-specific lab workflows. via @OpenAI 🔗 openai.com/index/introduc… #GPT #LLM

📈 TRENDING: GPT‑Rosalind tackles drug discovery with protein & genomics reasoning — faster hypothesis cycles. Recent arXiv work warns LLMs can make unrecoverable mid‑generation mistakes, so verifier layers are non‑negotiable. via @OpenAI #AI #BioTech #MachineLearning